Inspire Veterinary Partners | 10-Q: FY2025 Q1 Revenue: USD 3.639 M

Revenue: As of FY2025 Q1, the actual value is USD 3.639 M.

EPS: As of FY2025 Q1, the actual value is USD -0.43.

EBIT: As of FY2025 Q1, the actual value is USD -2.415 M.

Segment Revenue

• Service Revenue: $2,741,029 for the three months ended March 31, 2025, compared to $3,545,599 for the same period in 2024, representing a decrease of 23%.
• Product Revenue: $898,180 for the three months ended March 31, 2025, compared to $1,285,968 for the same period in 2024, representing a decrease of 30%.

Operational Metrics

• Net Loss: $2,415,036 for the three months ended March 31, 2025, compared to $3,421,792 for the same period in 2024, representing a decrease in net loss by 29%.
• Total Operating Expenses: $5,646,517 for the three months ended March 31, 2025, compared to $7,694,072 for the same period in 2024, representing a decrease of 27%.

Cash Flow

• Net Cash Used in Operating Activities: $1,374,297 for the three months ended March 31, 2025, compared to $3,169,029 for the same period in 2024.
• Net Cash Provided by Financing Activities: $2,528,915 for the three months ended March 31, 2025, compared to $3,216,090 for the same period in 2024.

Unique Metrics

• Adjusted Clinics EBITDA: $5,146 for the three months ended March 31, 2025, compared to $16,735 for the same period in 2024.

Future Outlook and Strategy

• Core Business Focus: The company plans to continue expanding its acquisition of veterinary hospitals, with a focus on general practice, specialty hospitals, and emergency care services. The strategy includes acquiring multi-unit practices to facilitate growth and enhance market presence.
• Non-Core Business: The company is exploring opportunities in mixed animal care, including equine and bovine care, as part of its long-term growth strategy.